Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
NCT01068483
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Colon Cancer
Ovarian Cancer
Endometrium Cancer
Interventions
DRUG:
BKM120
Sponsor
Novartis Pharmaceuticals